Elena Marchetti

Dr. Elena Marchetti


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2026 in Medicina
Verified
Journal Article
Open access
PDF file
EMElena Marchetti
Elena Marchetti
AMAngelo Melpignano
Angelo Melpignano
RPRita Pavasini
Rita Pavasini
Michele MalagùMichele Malagù
Michele Malagù
VFVitali Francesco
Vitali Francesco
FMFederico Marchini
Federico Marchini
Atrial fibrillation (AF) and heart failure (HF) frequently coexist and mutually worsen prognosis, creating a complex clinical scenario in which treatment decisions are increasingly imaging driven. Catheter ablation has emerged as a pivotal rhythm control strategy in selected patients with HF, but careful phenotyping of the atrial and ventricular substrate is essential to balance potential benefits against procedural risk and the likelihood of durable sinus rhythm. In this narrative review, we summarize the role of multimodality imaging across the entire AF care pathway in patients with HF, from candidate selection to intraprocedural guidance and post-ablation follow-up. Ultrasound imaging remains the cornerstone of pre-procedural assessment. Cardiac computed tomography (CCT) refines anatomical characterization of the left atrium, pulmonary veins, and left atrial appendage. Cardiovascular magnetic resonance (CMR) offers comprehensive tissue characterization of atrial and ventricular fibrosis, allowing distinction between atrial primary and atrial secondary AF phenotypes and informing expectations of reverse remodelling. During ablation, intracardiac echocardiography and transesophageal echocardiography optimize transseptal access, catheter navigation, and complication monitoring, and they are particularly relevant with contemporary Pulsed Field Ablation systems. In follow-up, echocardiography, CCT, and CMR are pivotal for quantifying structural reverse remodelling and detecting rare but life-threatening complications such as atrio esophageal fistula and pulmonary vein stenosis. An integrated, multimodality, substrate-based imaging strategy is therefore crucial to personalize rhythm versus rate control decisions and to guide safe, effective ablation in patients with AF and HF.

24 September 2026 in Medicina
Verified
Journal Article
Open access
PDF file
LRLaura Rotondo
Laura Rotondo
EMElena Marchetti
Elena Marchetti
RPRita Pavasini
Rita Pavasini
Elisabetta TonetElisabetta Tonet
Elisabetta Tonet
CTCarlo Tumscitz
Carlo Tumscitz
FMFederico Marchini
Federico Marchini
Normal-flow, low-gradient aortic stenosis is one of the most deceptive presentations of aortic stenosis. It leaves clinicians uncertain whether they are facing true severe disease or a measurement artefact. This often reflects a discordant grading pattern, in which many patients ultimately prove to have moderate disease. This diagnostic paradox arises from a combination of measurement errors, geometric assumptions, and genuine hemodynamic complexity, and cannot be resolved by echocardiography alone. A structured multimodality imaging strategy integrating calcium score evaluation on cardiac computed tomography, tissue characterisation on cardiac magnetic resonance and, when necessary, invasive hemodynamic assessment is the only reliable path to diagnostic certainty and appropriate therapeutic decision-making. Together, these modalities form a coherent sequential algorithm that moves from the non-invasive to the invasive, from the hemodynamic to the biological, and from uncertainty to actionable clinical decision. This review provides an updated, critical appraisal of each imaging tool and its respective strengths and pitfalls.